The impact of rarity in NICE ’s health technology appraisals
In the absence of a framework designed to evaluate medicines for rare diseases in the UK, most orphan medicines are appraised by the National Institute for Health and Care Excellence (NICE) through the Single ...
Source: Orphanet Journal of Rare Diseases - Category: Internal Medicine Authors: Sophie Clarke, Michelle Ellis and Jack Brownrigg Tags: Research Source Type: research